Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
Enteric fever caused by Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi is still a major disease burden mainly in developing countries. Previously, S. Typhi was believed to be the major cause of enteric fever. The real situation is now becoming clear with reports emerging from many Asian countries of S. Paratyphi, mostly S. Paratyphi A, causing a substantial number of cases of enteric fever. Although there have been advances in the use of the currently available typhoid vaccines and in the development of newer typhoid vaccines, paratyphoid vaccine development is lagging behind. Since the disease caused by S. Typhi and S. Paratyphi are clinically indistinguishable and are commonly termed 'enteric' fever, it will be necessary to have a vaccine available against both S. Typhi and S. Paratyphi A as a bivalent 'enteric fever vaccine'.
International Vaccine Institute, San 4-8, Nakseongdae-dong, Gwanak-gu, Seoul, 151-919, Korea.
Sushant
S
Sahastrabuddhe
Rodney
R
Carbis
Thomas F
TF
Wierzba
R Leon
RL
Ochiai
D001208:Asia / Q000453:epidemiology; D003906:Developing Countries; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D010284:Paratyphoid Fever / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D022562:Salmonella Vaccines / Q000276:immunology* / Q000302:isolation & purification*; D012482:Salmonella paratyphi A / Q000276:immunology* / Q000302:isolation & purification
D022562:Salmonella Vaccines